About Hemostasis
Hemostasis is a company based in Saint Paul (United States) founded in 2006. It operates as a B2B. Hemostasis has completed 1 acquisition, including Fiagon. Hemostasis offers products and services including PosiSep® X, PosiSep® Hemostat, Accel®, NexStat®, and Vectra F ™. Hemostasis operates in a competitive market with competitors including Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Glycologix, among others.
- Headquarter Saint Paul, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Hemostasis, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hemostasis
Hemostasis offers a comprehensive portfolio of products and services, including PosiSep® X, PosiSep® Hemostat, Accel®, NexStat®, and Vectra F ™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hemostat for sinus procedures to control bleeding and aid healing.
Device for nasal bleeding control with tissue separation capabilities.
Powder to stop bleeding in surgical environments quickly and effectively.
Topical powder for external wound hemostasis and patient care.
Micro-sponge for targeted drug delivery in medical treatments.
Funding Insights of Hemostasis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Hemostasis
Hemostasis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fiagon. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical navigation systems for surgical applications to healthcare providers
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Hemostasis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hemostasis Comparisons
Competitors of Hemostasis
Hemostasis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Glycologix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hematology products and solutions are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Catheters for venous clot management and removal are developed.
|
|
| domain | founded_year | HQ Location |
Magnetic therapy is developed to treat blood-borne diseases.
|
|
| domain | founded_year | HQ Location |
Blood cleansing treatment device
|
|
| domain | founded_year | HQ Location |
Biopolymers are developed for soft tissue protection and repair.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hemostasis
Frequently Asked Questions about Hemostasis
When was Hemostasis founded?
Hemostasis was founded in 2006.
Where is Hemostasis located?
Hemostasis is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
What does Hemostasis do?
Hemostasis, LLC is a medical technology company specializing in hemostatic products made from chitosan biopolymers. They design and produce devices like PosiSep for controlling bleeding in surgical and hospital settings, collaborating with physicians to enhance efficacy and patient outcomes. Based in Saint Paul, Minnesota, USA, the company serves global healthcare providers by innovating wound healing solutions and offering products for various medical applications.
Who are the top competitors of Hemostasis?
Hemostasis's top competitors include Haemonetics, Glycologix and Vetex Medical.
What products or services does Hemostasis offer?
Hemostasis offers PosiSep® X, PosiSep® Hemostat, Accel®, NexStat®, and Vectra F ™.
How many acquisitions has Hemostasis made?
Hemostasis has made 1 acquisition, including Fiagon.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.